Difference between revisions of "DZI20-197-Case-6"

From MGH Learn Pathology
(Edited automatically from page DZI20-197.)
(Automatic edit to upgrade to new templates)
Line 1: Line 1:
{{dziCase
+
{{ServiceRequestCase
|qc=yes
+
|identifier=DZI20-197-Case-6
|qcuser=Aja51
+
|intent=order
|qctime=Nov 02, 2020 21:27:55
+
|category=409073007
|order_date=October 22, 2020 12:31:43 PM
+
|priority=routine
|user=Mjf79
+
|orderDetail=case
|dziorder=DZI20-197
+
|locationCode=learn
|case_id=6
+
|basedOn=DZI20-197
|publish_timestamp=2020/12/11 13:00
+
|code=study
|clinical_hx=75 yo M with multiple lung nodules
+
|requisition=Frozen Conference
|case_diagnosis=FX1 (RML wedge): benign intraparenchymal lymph node, no carcinoma seen. FX2 (RUL subpleural nodule): adenocarcinoma with features suggestive of metastasis, FX2A (RUL dominant mass): Adenocarcinoma with papillary,  micropapillary and acinar patterns.
+
|supportingInfo=FX1 (RML wedge): benign intraparenchymal lymph node, no carcinoma seen. FX2 (RUL subpleural nodule): adenocarcinoma with features suggestive of metastasis, FX2A (RUL dominant mass): Adenocarcinoma with papillary,  micropapillary and acinar patterns.
 
Final: FX1: one benign intrapulmonary lymph node. FX2: Multiple foci of metastatic prostatic adenocarcinoma FX2A: Papillary adenocarcinoma of the lung (lepidic 30%, acinar mod diff 20%, papillary 45%, micropapillary 5%)
 
Final: FX1: one benign intrapulmonary lymph node. FX2: Multiple foci of metastatic prostatic adenocarcinoma FX2A: Papillary adenocarcinoma of the lung (lepidic 30%, acinar mod diff 20%, papillary 45%, micropapillary 5%)
 +
|reasonCode=75 yo M with multiple lung nodules
 +
|subject=public
 +
|performer=Al603
 +
|authoredOn=October 22, 2020 12:31:43 PM
 +
|requester=Mjf79
 +
|sequence=6
 
}}
 
}}
{{dziSlide
+
{{Media
|order_date=October 22, 2020 12:31:43 PM
+
|basedOn=DZI20-197-Case-6
|user=Mjf79
+
|type=image
|source_filename=Z0FBQUFBQmZrWHo5NFU0anRLVlE1VnJIZWItNklNSUpBQXBZYUJSVkFEbEFsZlZ1V09mMlgxVG5wNXpLb2x6a24yM2RLLTFKby1oMkhjUnFwWnROek1Da0xXdDFDNnNEbEE9PQ
+
|view=show
|slide_stain=H&E
+
|partOf=DZI20-197
|slide_anatomy=Show
+
|frames=1
 +
|reasonCode=H&E
 +
|identifier=DZI20-197-Case-6_1
 +
|createdDateTime=October 22, 2020 12:31:43 PM
 +
|operator=Mjf79
 +
|subject=Z0FBQUFBQmZrWHo5NFU0anRLVlE1VnJIZWItNklNSUpBQXBZYUJSVkFEbEFsZlZ1V09mMlgxVG5wNXpLb2x6a24yM2RLLTFKby1oMkhjUnFwWnROek1Da0xXdDFDNnNEbEE9PQ
 +
|modality=mrxs
 
}}
 
}}
{{dziSlide
+
{{Media
|order_date=October 22, 2020 12:35:29 PM
+
|basedOn=DZI20-197-Case-6
|user=Mjf79
+
|type=image
|source_filename=Z0FBQUFBQmZrWHotWXhJWDZ4T2dqUFdrdDZLVldlS0JITTJLOHZ6LUdzRFhtTXRHSkxYSGdwaUM5ODhheGZ0TlN0WjVPN3ZHcG44dXN1VnVKUFpPd3JZekcxRUJQUEQ2YWc9PQ
+
|view=show
|slide_stain=H&E
+
|partOf=DZI20-197
|slide_anatomy=Show
+
|frames=2
 +
|reasonCode=H&E
 +
|identifier=DZI20-197-Case-6_2
 +
|createdDateTime=October 22, 2020 12:35:29 PM
 +
|operator=Mjf79
 +
|subject=Z0FBQUFBQmZrWHotWXhJWDZ4T2dqUFdrdDZLVldlS0JITTJLOHZ6LUdzRFhtTXRHSkxYSGdwaUM5ODhheGZ0TlN0WjVPN3ZHcG44dXN1VnVKUFpPd3JZekcxRUJQUEQ2YWc9PQ
 +
|modality=mrxs
 
}}
 
}}
{{dziSlide
+
{{Media
|order_date=October 22, 2020 12:35:29 PM
+
|basedOn=DZI20-197-Case-6
|user=Mjf79
+
|type=image
|source_filename=Z0FBQUFBQmZrWDBERVVzWGowUktFUk5FcUVodWtvOWROR25yUzFMTDJnN2lhaDladXNmUF9kUkluY0gtR05mOW9GMzNKdk5mY1ZyazJ4UXZ3YmR2N0RrWDVGMXNWb0JjTGc9PQ
+
|view=show
|slide_stain=H&E
+
|partOf=DZI20-197
|slide_anatomy=Show
+
|frames=3
 +
|reasonCode=H&E
 +
|identifier=DZI20-197-Case-6_3
 +
|createdDateTime=October 22, 2020 12:35:29 PM
 +
|operator=Mjf79
 +
|subject=Z0FBQUFBQmZrWDBERVVzWGowUktFUk5FcUVodWtvOWROR25yUzFMTDJnN2lhaDladXNmUF9kUkluY0gtR05mOW9GMzNKdk5mY1ZyazJ4UXZ3YmR2N0RrWDVGMXNWb0JjTGc9PQ
 +
|modality=mrxs
 
}}
 
}}

Revision as of 13:48, March 9, 2022

DZI20-197-Case-6
75 yo M with multiple lung nodules
FX1 (RML wedge): benign intraparenchymal lymph node, no carcinoma seen. FX2 (RUL subpleural nodule): adenocarcinoma with features suggestive of metastasis, FX2A (RUL dominant mass): Adenocarcinoma with papillary, micropapillary and acinar patterns. Final: FX1: one benign intrapulmonary lymph node. FX2: Multiple foci of metastatic prostatic adenocarcinoma FX2A: Papillary adenocarcinoma of the lung (lepidic 30%, acinar mod diff 20%, papillary 45%, micropapillary 5%)
December 31, 1969 7:00:00 PM